Rainbow Childrens Medicare financials

Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹470cr+33.2% on Q1 FY26
Net profit
₹62.5cr+16.2% on Q1 FY26
EBITDA margin
28.7%−0.7 pts on Q1 FY26
EPS
₹5.97+13.3% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue470353+33.2%
EBITDA135104+29.9%
EBITDA margin28.7%29.4%−0.7 pts
Profit before tax84.071.4+17.6%
Net profit62.553.8+16.2%
EPS₹5.97₹5.27+13.3%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹470 crNet profit₹62.5 crNet margin13.3%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
12,236————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
43843859131873.5
15.515.56.86.05.0
11,813————
1,8201,7031,5161,2971,174
—+12.4%+16.9%+10.5%—
575544490429396
31.6%32.0%32.3%33.1%33.8%
417394351317306
290282244218212
15.9%16.5%16.1%16.8%18.1%
₹28.10₹27.41₹23.97₹21.37₹20.76
—+14.3%+12.2%+2.9%—
—420396321327
—−216−146−354−141
203203250−32.2186
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RAINBOW₹1,204.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹12,236 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————12,235.8
- Cash, Equiv & ST Investments73.5317.6591.0438.4438.4
+ Minority Interest5.06.06.815.515.5
Enterprise Value————11,813.0
Revenue1,173.61,296.91,515.91,703.11,820.1
Growth %, YoY—+10.5+16.9+12.4—
EBITDA396.4428.9489.9544.2575.2
Margin %33.7833.0732.3231.9531.60
EBIT306.1316.8351.4393.6416.6
Net Income212.4218.3244.2281.5290.3
Margin %18.1016.8316.1116.5315.95
EPS, Adj (current shares)20.7621.3723.9727.4128.10
Growth %, YoY—+2.9+12.2+14.3—
Cash from Operations327.2321.4395.7419.7—
Capital Expenditures-141.3-353.6-145.7-216.5—
Free Cash Flow185.9-32.2250.0203.2203.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Rainbow Childrens Medicare financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Rainbow Childrens Medicare (NSE: RAINBOW) had a market capitalisation of ₹12,155 crore at the 29 October 2026 close (₹1,196.80 a share), a PE ratio of 42.6 on the last four quarters' profit and a price-to-book ratio of 7.38. In FY26 its consolidated net profit attributable to shareholders was ₹278 crore on revenue of ₹1,703 crore; in Q1 FY27 (April–June 2026) it was ₹60.6 crore, up 13.2% year on year. It had no borrowings on 31 March 2026. Promoters held 49.83% of the shares on 30 September 2026.

Share price used
₹1,196.80 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Rainbow Childrens Medicare at a glance · consolidated

Market cap
₹12,155 Crat ₹1,196.80 · 29 Oct close
PE ratio (last 4 quarters)
42.643.7 on FY26 profit
Price to book (PB)
7.38book value ₹162.27 a share
ROE (FY26)
17.9%unchanged vs FY25ROCE 16.3%
Debt to equity
0.00net cash ₹438 Cr
Promoter holding
49.83%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.29%₹3.50 a share in 12 months
Net worth
₹1,648 Cr+12.3% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹203 Cr−18.7% vs FY25

Questions

What is the Rainbow Childrens Medicare PE ratio today?

Rainbow Childrens Medicare's PE ratio is 42.6 at the 29 October 2026 close (₹1,196.80 a share): a market capitalisation of ₹12,155 crore divided by consolidated net profit attributable to shareholders of ₹285 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹278 crore) it is 43.7.

What is the Rainbow Childrens Medicare PB ratio (price to book value)?

Rainbow Childrens Medicare's price-to-book (PB) ratio is 7.38 at the 29 October 2026 close: a market capitalisation of ₹12,155 crore divided by shareholders' equity (book value) of ₹1,648 crore on 31 March 2026. That is a book value of ₹162.27 per share against a share price of ₹1,196.80.

What is the Rainbow Childrens Medicare net worth?

Rainbow Childrens Medicare's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,648 crore on 31 March 2026, up 12.3% from ₹1,468 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹12,155 crore at the 29 October 2026 close.

What is the Rainbow Childrens Medicare market cap?

Rainbow Childrens Medicare's market capitalisation was ₹12,155 crore at the 29 October 2026 close: 10.16 crore shares at ₹1,196.80 each.

Is Rainbow Childrens Medicare debt free?

Yes. Rainbow Childrens Medicare had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹438 crore of cash, bank balances and current investments.

What is the Rainbow Childrens Medicare EPS?

Rainbow Childrens Medicare's basic earnings per share (EPS) were ₹27.41 in FY26, against ₹23.97 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹28.11.

What is the Rainbow Childrens Medicare debt to equity ratio?

Rainbow Childrens Medicare's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹1,664 crore. A year earlier, on 31 March 2025, it was 0.00.

What is the Rainbow Childrens Medicare book value per share?

Rainbow Childrens Medicare's book value per share was ₹162.27 on 31 March 2026: shareholders' equity of ₹1,648 crore divided by the 10.16 crore shares in issue, up 12.2% from ₹144.58 a year earlier. The share price at the 29 October 2026 close was ₹1,196.80.

What is the Rainbow Childrens Medicare dividend yield?

Rainbow Childrens Medicare's dividend yield is 0.29% at the 29 October 2026 close: dividends of ₹3.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,196.80. They were ₹3.50 on 21 July 2026.

What is the Rainbow Childrens Medicare ROE and ROCE?

In FY26, Rainbow Childrens Medicare's return on equity (ROE) was 17.9% and its return on capital employed (ROCE) was 16.3%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 17.9% and ROCE 16.6%.

What is the Rainbow Childrens Medicare promoter holding?

Promoters held 49.83% of Rainbow Childrens Medicare on 30 September 2026, down 0.01 percentage points from 49.84% the previous quarter and down 0.02 percentage points from 49.85% a year earlier, according to the shareholding pattern filed with NSE.

What is the Rainbow Childrens Medicare shareholding pattern?

On 30 September 2026, Rainbow Childrens Medicare's shares were held by promoters 49.83%, foreign portfolio investors (FII/FPI) 14.66%, domestic institutions (DII) 23.28% (including mutual funds at 18.84%) and retail and other non-institutional investors 11.83%. Over the year, FII holding was down 7.19 percentage points from 21.85% and DII holding was up 5.82 percentage points from 17.46%.

What is the Rainbow Childrens Medicare dividend in 2026 and its record date?

In 2026, Rainbow Childrens Medicare has declared one dividend: ₹3.50 with record date 21 July 2026.

What is the Rainbow Childrens Medicare free cash flow?

In FY26, Rainbow Childrens Medicare generated ₹420 crore of cash from operations and spent ₹216 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹203 crore. In FY25 it was ₹250 crore.

When are the Rainbow Childrens Medicare next results?

Rainbow Childrens Medicare will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, the date of the board meeting it has notified to the exchanges.

What are the Rainbow Childrens Medicare latest quarterly results?

Rainbow Childrens Medicare's latest results are for Q1 FY27 (April–June 2026), filed on 30 July 2026: consolidated net profit attributable to shareholders ₹60.6 crore, up 13.2% from ₹53.5 crore in Q1 FY26; revenue from operations ₹470 crore, up 33.2% year on year.

What is the Rainbow Childrens Medicare revenue and profit in FY26?

In FY26 (April 2025–March 2026), Rainbow Childrens Medicare's consolidated net profit attributable to shareholders was ₹278 crore, up 14.3% from ₹243 crore in FY25, on revenue from operations of ₹1,703 crore (up 12.4%). Over three years, from FY23, net profit was up 32.0%.

How does the Rainbow Childrens Medicare PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Rainbow Childrens Medicare's PE ratio is 43.7, the lowest of the four: Apollo Hospitals Enterprise 60.7, Fortis Healthcare 54.7 and Krishna Institute of Medical Sciences 122.2, a peer average of 79.2. Each is the company's market capitalisation at that price divided by its FY26 net profit.

How does Rainbow Childrens Medicare compare with its peers?

On FY26 consolidated figures, against Apollo Hospitals Enterprise, Fortis Healthcare and Krishna Institute of Medical Sciences: Rainbow Childrens Medicare's operating margin of 23.1% is the highest of the four (Apollo Hospitals Enterprise 11.5%, Fortis Healthcare 17.9%, Krishna Institute of Medical Sciences 13.3%; peer average 14.2%); its return on equity of 17.9% is the second highest of the four (Apollo Hospitals Enterprise 22.0%, Fortis Healthcare 11.1%, Krishna Institute of Medical Sciences 11.0%; peer average 14.7%); its revenue growth over three years of 13.2% a year is the third highest of the four (Apollo Hospitals Enterprise 14.9% a year, Fortis Healthcare 13.2% a year, Krishna Institute of Medical Sciences 21.1% a year; peer average 16.4% a year).

Rainbow Childrens Medicare vs Apollo Hospitals Enterprise: how do they compare?

In FY26, Rainbow Childrens Medicare earned net profit attributable to shareholders of ₹278 crore on revenue of ₹1,703 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Rainbow Childrens Medicare's operating margin was 23.1% (Apollo Hospitals Enterprise 11.5%) and its return on equity 17.9% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Rainbow Childrens Medicare's market capitalisation was ₹12,155 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 43.7 against 60.7.

Where do these Rainbow Childrens Medicare figures come from?

From Rainbow Childrens Medicare's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.